腫瘤學(xué)細(xì)胞分化課件_第1頁(yè)
腫瘤學(xué)細(xì)胞分化課件_第2頁(yè)
腫瘤學(xué)細(xì)胞分化課件_第3頁(yè)
腫瘤學(xué)細(xì)胞分化課件_第4頁(yè)
腫瘤學(xué)細(xì)胞分化課件_第5頁(yè)
已閱讀5頁(yè),還剩27頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

CellDifferentiation&Cancer腫瘤學(xué)細(xì)胞分化細(xì)胞分化(differentiation)是指同源細(xì)胞逐漸發(fā)育成具備穩(wěn)定形態(tài)結(jié)構(gòu)、生理功能和生化特征的另一類型細(xì)胞的過(guò)程。細(xì)胞分化過(guò)程是由一系列基因產(chǎn)物(regulatoryproteins)調(diào)控的。

i.e.,每個(gè)基因的表達(dá)都必須:在正確的細(xì)胞中;在正確的時(shí)間;對(duì)正確的信號(hào)產(chǎn)生正確的反應(yīng);產(chǎn)生正確的表達(dá)水平。腫瘤學(xué)細(xì)胞分化例子:眼形成的關(guān)鍵調(diào)控蛋白Ey(果蠅)ey

基因早期細(xì)胞(發(fā)育成腿)腿中眼細(xì)胞分化眼形成腫瘤學(xué)細(xì)胞分化InductionofPluripotentStemCellsfromAdultHumanFibroblastsbyDefinedFactorsCell2007,131,861-872(Oct3/4,Sox2,Klf4,c-Myc

)腫瘤學(xué)細(xì)胞分化腫瘤學(xué)細(xì)胞分化LeukemiaAcuteChronicLymphoidMyeloidLymphoidMyeloid(CLL)(CML)(ALL)AMLM0M1M2M3M4M5M6M7FAB:腫瘤學(xué)細(xì)胞分化

M2t(8;21)AML1-ETOM1t(9;22)M5t(9;11)M3t(15;17)PML-RARαacutepromyelocyticleukemia“Acutemyelogenousleukemias(AMLs)aregeneticallyheterogeneousandcharacterizedbychromosomalrearrangementsthatproducefusionproteinswithaberranttranscriptionalregulatoryactivities.”MyriamAlcalayet.al.,2003FAB,TranslocationandFusionProteins腫瘤學(xué)細(xì)胞分化M3t(15;17)PML-RARαacutepromyelocyticleukemia“Acutepromyelocyticleukemia(AMLM3)isnowthemostfrequentlycurableacuteleukaemiainadultsifpromptlydiagnosedandadequatelytreated.”ParmarS,TallmanMS.,2003腫瘤學(xué)細(xì)胞分化DifferentiationTherapyDifferentiationtherapiesarebroadlydefinedasthosethatinducemalignantreversion(i.e.themalignantphenotypebecomesbenign).Clinically,thesetherapieshavebeenmostsuccessfulforacutepromyelocyticleukemia(APL),withtheuseofall-transretinoicacid(ATRA).Thistreatmenthaschangedacancerwithapreviouslydismaloutcomeintooneofthemosttreatableformsofleukemia.Theexactmechanismsofdifferentiationareunknown—itisunclearifitoccursbyinducingterminaldifferentiation(G0arrest),byinducingdifferentiation‘backwards’tothenon-malignantformofthecell,orbytriggeringapoptosis.ItislikelythatitinvolvesallofthesepathwaysAlexanderISpiraet.Al.,Differentiationtherapy,CurrentOpinioninPharmacology2003腫瘤學(xué)細(xì)胞分化1949:describedinFranceasaleukemiawithexaggeratedhemorrhagicsymptoms1957Hillestadcoinsitpromyelocyticleukemia1977t(15;17)describedinthreeptsRowleyetalLancet.DrugGeneATRAandacutepromyelocyticleukemia

(APL)腫瘤學(xué)細(xì)胞分化1988:Breakthroughintreatment

fromChina腫瘤學(xué)細(xì)胞分化1990:MultiplegroupsidentifyRARaast(15;17)breakpoint腫瘤學(xué)細(xì)胞分化AcutePromyelocyticLeukemiaSTAT5b(17q21)Blood93,3167(1999)腫瘤學(xué)細(xì)胞分化Howdoyoutestifafusionproteinisoncogenic?+PNAS96,15103(1999)腫瘤學(xué)細(xì)胞分化HowdoesPML-RARainducesAPL?

HowdoesATRAinduceremission?腫瘤學(xué)細(xì)胞分化LossofactivationdomainCoiled-coildomainallowsdimerization腫瘤學(xué)細(xì)胞分化CorepressorCoactivatorRARRXR腫瘤學(xué)細(xì)胞分化Jepsen,K.etal.JCellSci2002;115:689-698Transcriptionalrepressionbynuclearreceptorsisregulatedbyrecruitmentoftheco-repressorsN-CoRand/orSMRT腫瘤學(xué)細(xì)胞分化Atsumi,Aetal

BBRC(2006)345:1475HDAC3RecruitmentAbolishedbyATRAGraphicfromMillipore腫瘤學(xué)細(xì)胞分化ATRAresolvesthedifferentiationblockint(15;17)acutemyeloidleukemiabyrestoringPU.1expression腫瘤學(xué)細(xì)胞分化Figure1.ConditionalexpressionofPML-RARAinmyeloidcellssuppressesPU.1.Figure2.LeukemiccellsfromapatientwithAPL(HT93cells)havesuppressedPU.1expression.腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure3.ATRArestoresPU.1expressioninAPLcells腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure4.CEBPfactorsandOCT-1induceactivityoftheproximalPU.1promoterinHT93AAPLcellsfollowingATRAstimulation腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure5.PU.1expressioninprimaryAPLcells:inversecorrelationwithPML-RARAatdiagnosis,andinductionofexpressionfollowingtreatmentwithATRAinvivo腫瘤學(xué)細(xì)胞分化Copyright?2006AmericanSocietyofHematology.Copyrightrestrictionsmayapply.Mueller,B.U.etal.Blood2006;107:3330-3338Figure6.RestoringPU.1expressioninPML-RARAleukemiccellsinducesgranulocyticdifferentiation腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure7.ReductionofPU.1expressionbysiRNAblocksATRA-induceddifferentiationofHT93AcellsPU.1expression腫瘤學(xué)細(xì)胞分化hCG-PML-RARaPU.1+/-F1cross(informativeprogeny)Wild-typePU.1+/-hCG-PML-RARahCG-PML-RARa XPU.1+/-DoeslossofonecopyofPU.1contributetoPML-RARadrivenAPL?

LowpenetranceofAPL?腫瘤學(xué)細(xì)胞分化YES:PU.1+/-miceexpressing

PML-RARahaveahighpenetranceofAPLPNAS102,12513(2005)腫瘤學(xué)細(xì)胞分化PU.1mutations

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論